246 related articles for article (PubMed ID: 21440204)
1. Cardiac biomarkers in the critically ill.
Ventetuolo CE; Levy MM
Crit Care Clin; 2011 Apr; 27(2):327-43. PubMed ID: 21440204
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular biomarkers in the ICU.
Noveanu M; Mebazaa A; Mueller C
Curr Opin Crit Care; 2009 Oct; 15(5):377-83. PubMed ID: 19606027
[TBL] [Abstract][Full Text] [Related]
3. Use of cardiac biomarkers in neonatology.
Vijlbrief DC; Benders MJ; Kemperman H; van Bel F; de Vries WB
Pediatr Res; 2012 Oct; 72(4):337-43. PubMed ID: 22797141
[TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
Green SM; Green JA; Januzzi JL
Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
[TBL] [Abstract][Full Text] [Related]
5. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
6. Serum biomarkers for heart failure.
Jarolim P
Cardiovasc Pathol; 2006; 15(3):144-9. PubMed ID: 16697927
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency.
Yamashita T; Seino Y; Ogawa A; Ogata K; Fukushima M; Tanaka K; Mizuno K
J Cardiol; 2010 May; 55(3):377-83. PubMed ID: 20350516
[TBL] [Abstract][Full Text] [Related]
8. In critically ill patients, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels correlate with C-reactive protein values and leukocyte counts.
Rudiger A; Fischler M; Harpes P; Gasser S; Hornemann T; von Eckardstein A; Maggiorini M
Int J Cardiol; 2008 May; 126(1):28-31. PubMed ID: 17477984
[TBL] [Abstract][Full Text] [Related]
9. Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men.
Kurl S; Ala-Kopsala M; Ruskoaho H; Mäkikallio T; Nyyssönen K; Vuolteenaho O; Sivenius J; Salonen JT; Laukkanen JA
Heart; 2009 Jul; 95(13):1067-71. PubMed ID: 19321489
[TBL] [Abstract][Full Text] [Related]
10. Standardization of cardiac markers.
Apple FS
Scand J Clin Lab Invest Suppl; 2005; 240():107-11. PubMed ID: 16112967
[TBL] [Abstract][Full Text] [Related]
11. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.
O'Donoghue M; de Lemos JA; Morrow DA; Murphy SA; Buros JL; Cannon CP; Sabatine MS
Circulation; 2006 Aug; 114(6):550-7. PubMed ID: 16880323
[TBL] [Abstract][Full Text] [Related]
12. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism.
Kaczyñska A; Pelsers MM; Bochowicz A; Kostrubiec M; Glatz JF; Pruszczyk P
Clin Chim Acta; 2006 Sep; 371(1-2):117-23. PubMed ID: 16698008
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biomarker profile of trauma-induced secondary cardiac injury.
De'Ath HD; Rourke C; Davenport R; Manson J; Renfrew I; Uppal R; Davies LC; Brohi K
Br J Surg; 2012 Jun; 99(6):789-97. PubMed ID: 22437496
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic peptide: a universal cardiac biomarker?
Teodorovich N; Krakover R; Vered Z
Isr Med Assoc J; 2008 Feb; 10(2):152-3. PubMed ID: 18432033
[No Abstract] [Full Text] [Related]
15. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS
N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742
[TBL] [Abstract][Full Text] [Related]
16. Cardiac biomarkers in chronic renal disease.
Collinson PO; Gaze DC
Scand J Clin Lab Invest Suppl; 2008; 241():104-8. PubMed ID: 18569976
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children.
Maher KO; Reed H; Cuadrado A; Simsic J; Mahle WT; Deguzman M; Leong T; Bandyopadhyay S
Pediatrics; 2008 Jun; 121(6):e1484-8. PubMed ID: 18519452
[TBL] [Abstract][Full Text] [Related]
18. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
[TBL] [Abstract][Full Text] [Related]
19. New horizons: NT-proBNP for risk stratification of patients with shock in the intensive care unit.
Hoffmann U; Borggrefe M; Brueckmann M
Crit Care; 2006; 10(2):134. PubMed ID: 16594987
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care.
Thygesen K; Mair J; Mueller C; Huber K; Weber M; Plebani M; Hasin Y; Biasucci LM; Giannitsis E; Lindahl B; Koenig W; Tubaro M; Collinson P; Katus H; Galvani M; Venge P; Alpert JS; Hamm C; Jaffe AS;
Eur Heart J; 2012 Aug; 33(16):2001-6. PubMed ID: 21292681
[No Abstract] [Full Text] [Related]
[Next] [New Search]
